Abiopharma

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

New Form 4 - ECOLAB INC. Filed: 2025-05-14 AccNo: 0001415889-25-012903 Size: 8 KB

New Form 4 - ATI Physical Therapy, Inc. Filed: 2025-05-14 AccNo: 0001927109-25-000003 Size: 5 KB

Hawkins, Inc. Declares Quarterly Cash Dividend of $0.18 Per Share

New Form 4 - ECOLAB INC. Filed: 2025-05-14 AccNo: 0001415889-25-012899 Size: 6 KB

New Form 4 - HARROW, INC. Filed: 2025-05-14 AccNo: 0001641172-25-010340 Size: 9 KB

Hawkins, Inc. Reports Fourth Quarter and Fiscal Year 2025 Results

New Form 4/A - HARROW, INC. Filed: 2025-05-14 AccNo: 0001641172-25-010338 Size: 7 KB

New Form 4 - ECOLAB INC. Filed: 2025-05-14 AccNo: 0001415889-25-012896 Size: 6 KB

New Form 4/A - HARROW, INC. Filed: 2025-05-14 AccNo: 0001641172-25-010335 Size: 7 KB

New Form 8-K - Biofrontera Inc. Filed: 2025-05-14 AccNo: 0001641172-25-010330 Size: 270 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 4 - ECOLAB INC. Filed: 2025-05-14 AccNo: 0001415889-25-012893 Size: 6 KB

New Form 10-Q - Precipio, Inc. Filed: 2025-05-14 AccNo: 0001558370-25-007776 Size: 7 MB

New Form 10-Q - Akari Therapeutics Plc Filed: 2025-05-14 AccNo: 0000950170-25-071563 Size: 10 MB

New Form 10-Q - CV Sciences, Inc. Filed: 2025-05-14 AccNo: 0000950170-25-071559 Size: 8 MB